Navigating Policy Shifts at the FDA, USPTO, and NIH: Strategic & Legal Insights for Biotech Entrepreneurs

​So You Want to Do Business with the Government
Unlock Strategic Insights for Biotechnology Innovators

​Biotechnology entrepreneurs, this is your chance to gain critical knowledge to navigate the evolving intersection of federal policies and biotech innovation. Join WilmerHale Partners for a comprehensive discussion covering NIH grants, FDA reviews and timelines, USPTO policies, and intellectual property strategies.

​Meet the Experts:

• ​Barish Ozdamar: Renowned for his expertise in intellectual property disputes and IP portfolio development, Dr. Ozdamar brings deep insights into areas like gene therapy, CRISPR, vaccines, diagnostics, and more.

• ​Barry J. Hurewitz: With his multidisciplinary experience in government transactions and regulation of technology, Mr. Hurewitz will guide you through key strategies in funding opportunities, compliance, and government rights in patents and data.

​Why Attend?

• ​Gain essential legal and strategic insights to adapt to shifting federal policies.

• ​Discover innovative approaches to intellectual property, and regulatory navigation considering the shift in administration and leadership.

• ​Participate in a dynamic Q&A session to address your specific challenges.

• ​Enjoy light refreshments and networking opportunities with experts and peers.

​About WilmerHale: With over 1,100 lawyers across 12 offices, WilmerHale is a leading international law firm at the forefront of government, technology, and business.